---
title: "febrile neutropenia low-risk"
slug: "febrile-neutropenia-low-risk"
date: "2023-12-12"
enableToc: false
tags:
  - building
---

> [!info]
>
> ðŸŒ± ä¾†è‡ª: [[Febrile Neutropenia]]

# febrile neutropenia low-risk

## Clinical Setting

- Febrile neutropenia: Post-cancer chemotherapy or post-allogeneic bone marrow transplant patient with fever (â‰¥38.3Â°C x 1 hr of sustained over 38Â°C) AND neutropenic (absolute neutrophil count range from <500-<1000 cells/Î¼L)
- Patient is considered low-risk and eligible for out-patient management if:
- Anticipate < 7 days of neutropenia
- No medical comorbidities (no renal or hepatic dysfunction)
- Can take oral medications
- 24/7 access to nearby ER, lab and x-ray and experienced providers
- Motivated and compliant patient and family

## Etiologies

- Bacteria: aerobic gram-negative bacilli (Enterobacteriaceae, Pseudomonas), aerobic gram-positive cocci (includes staphylococci and streptococci)
- Fungi: Candida sp > molds (rare in low-risk patients)
- Viral: respiratory viruses most common, HSV and VZV (rare in low-risk patients)

## Primary Regimens

- Ciprofloxacin 750 mg po bid + Amoxicillin-clavulanate 875 mg po bid
- Penicillin allergy: Can substitute Clindamycin 300 mg po q6h or q8h for Amoxicillin-clavulanate

## Alternative Regimens

- Moxifloxacin 400 mg po daily
